Organization Overview
Alternative names
lumateperone (Caplyta) (2019 NDA)
Alzheimer Disease (Phase 3)
Bipolar Disorder (Phase 3)
Dementia (Phase 3)
Depression (Phase 3)
Depressive Disorder (Phase 3)
Heart Failure (Phase 2)
Heart Failure, Systolic (Phase 2)
Parkinson Disease (Phase 2)
Psychomotor Agitation (Phase 3)
Schizophrenia (Phase 3)